These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 32210471)

  • 1. No clear associations of adult BMI and diabetes mellitus with non-muscle invasive bladder cancer recurrence and progression.
    Evers J; Grotenhuis AJ; Aben KKH; Kiemeney LALM; Vrieling A
    PLoS One; 2020; 15(3):e0229384. PubMed ID: 32210471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diabetes Mellitus and Obesity as Risk Factors for Bladder Cancer Prognosis: A Systematic Review and Meta-Analysis.
    Lu Y; Tao J
    Front Endocrinol (Lausanne); 2021; 12():699732. PubMed ID: 34690923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Body mass index and waist circumference in relation to risk of recurrence and progression after non-muscle invasive bladder cancer.
    van Zutphen M; Beeren I; Aben KKH; van der Heijden AG; Witjes JA; Kiemeney LALM; Vrieling A
    Cancer Med; 2023 Oct; 12(20):20459-20469. PubMed ID: 37800635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An increased body mass index is associated with a worse prognosis in patients administered BCG immunotherapy for T1 bladder cancer.
    Ferro M; Vartolomei MD; Russo GI; Cantiello F; Farhan ARA; Terracciano D; Cimmino A; Di Stasi S; Musi G; Hurle R; Serretta V; Busetto GM; De Berardinis E; Cioffi A; Perdonà S; Borghesi M; Schiavina R; Cozzi G; Almeida GL; Bove P; Lima E; Grimaldi G; Matei DV; Crisan N; Muto M; Verze P; Battaglia M; Guazzoni G; Autorino R; Morgia G; Damiano R; de Cobelli O; Shariat S; Mirone V; Lucarelli G
    World J Urol; 2019 Mar; 37(3):507-514. PubMed ID: 29992381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Body mass index and cancer incidence:a prospective cohort study in northern China].
    Guo L; Li N; Wang G; Su K; Li F; Yang L; Ren J; Chang S; Chen S; Wu S; He J; Dai M
    Zhonghua Liu Xing Bing Xue Za Zhi; 2014 Mar; 35(3):231-6. PubMed ID: 24831616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of diabetes mellitus and metformin use with oncological outcomes of patients with non-muscle-invasive bladder cancer.
    Rieken M; Xylinas E; Kluth L; Crivelli JJ; Chrystal J; Faison T; Lotan Y; Karakiewicz PI; Fajkovic H; Babjuk M; Kautzky-Willer A; Bachmann A; Scherr DS; Shariat SF
    BJU Int; 2013 Dec; 112(8):1105-12. PubMed ID: 24053906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of body mass on recurrence and progression in Chinese patients with Ta, T1 urothelial bladder cancer.
    Xu T; Zhu Z; Wang X; Xia L; Zhang X; Zhong S; Sun F; Zhu Y; Shen Z
    Int Urol Nephrol; 2015 Jul; 47(7):1135-41. PubMed ID: 26009259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diabetes mellitus with poor glycemic control increases bladder cancer recurrence risk in patients with upper urinary tract urothelial carcinoma.
    Tai YS; Chen CH; Huang CY; Tai HC; Wang SM; Pu YS
    Diabetes Metab Res Rev; 2015 Mar; 31(3):307-14. PubMed ID: 25363092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dietary patterns and risk of recurrence and progression in non-muscle-invasive bladder cancer.
    Westhoff E; Wu X; Kiemeney LA; Lerner SP; Ye Y; Huang M; Dinney CP; Vrieling A; Tu H
    Int J Cancer; 2018 May; 142(9):1797-1804. PubMed ID: 29235103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced estimated glomerular filtration rate (eGFR <60 mL/min/1.73 m
    Blute ML; Kucherov V; Rushmer TJ; Damodaran S; Shi F; Abel EJ; Jarrard DF; Richards KA; Messing EM; Downs TM
    BJU Int; 2017 Sep; 120(3):387-393. PubMed ID: 28464520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diabetes and the risk of bladder cancer subtypes in men and women: results from the Netherlands Cohort Study.
    van den Brandt PA
    Eur J Epidemiol; 2024 Apr; 39(4):379-391. PubMed ID: 38492115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Obesity and breast cancer outcomes in chemotherapy patients in New Zealand - a population-based cohort study.
    Elwood JM; Tin Tin S; Kuper-Hommel M; Lawrenson R; Campbell I
    BMC Cancer; 2018 Jan; 18(1):76. PubMed ID: 29334917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of recurrence in non-muscle invasive bladder cancer patients. Do patient characteristics matter?
    Ucpinar B; Erbin A; Ayranci A; Caglar U; Alis D; Basal S; Sarilar O; Akbulut MF
    J BUON; 2019; 24(4):1659-1665. PubMed ID: 31646822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The UroLife study: protocol for a Dutch prospective cohort on lifestyle habits in relation to non-muscle-invasive bladder cancer prognosis and health-related quality of life.
    de Goeij L; Westhoff E; Witjes JA; Aben KK; Kampman E; Kiemeney LA; Vrieling A
    BMJ Open; 2019 Oct; 9(10):e030396. PubMed ID: 31619424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Refraining from Smoking for 15 Years or More Reduced the Risk of Tumor Recurrence in Non-muscle Invasive Bladder Cancer Patients.
    Ogihara K; Kikuchi E; Yuge K; Ito Y; Tanaka N; Matsumoto K; Miyajima A; Asakura H; Oya M
    Ann Surg Oncol; 2016 May; 23(5):1752-9. PubMed ID: 26671037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence, Clinicopathological Risk Factors, Management and Outcomes of Nonmuscle Invasive Recurrence after Complete Response to Trimodality Therapy for Muscle Invasive Bladder Cancer.
    Sanchez A; Wszolek MF; Niemierko A; Clayman RH; Drumm M; Rodríguez D; Feldman AS; Dahl DM; Heney NM; Shipley WU; Zietman AL; Efstathiou JA
    J Urol; 2018 Feb; 199(2):407-415. PubMed ID: 28870862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of body mass index on the oncological outcomes of patients treated with radical cystectomy for muscle-invasive bladder cancer.
    Dabi Y; Rouscoff Y; Anract J; Delongchamps NB; Sibony M; Saighi D; Zerbib M; Peyraumore M; Xylinas E
    World J Urol; 2017 Feb; 35(2):229-235. PubMed ID: 27272203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diabetes mellitus with obesity is a predictor of recurrence in patients with non-metastatic renal cell carcinoma.
    Fukushima H; Masuda H; Yokoyama M; Tatokoro M; Yoshida S; Ishioka J; Matsuoka Y; Numao N; Koga F; Saito K; Fujii Y; Kihara K
    Jpn J Clin Oncol; 2013 Jul; 43(7):740-6. PubMed ID: 23729495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Construction of predictive models for recurrence and progression in >1000 patients with non-muscle-invasive bladder cancer (NMIBC) from a single centre.
    Ali-El-Dein B; Sooriakumaran P; Trinh QD; Barakat TS; Nabeeh A; Ibrahiem el-HI
    BJU Int; 2013 Jun; 111(8):E331-41. PubMed ID: 23445082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overweight, Obesity, and Postmenopausal Invasive Breast Cancer Risk: A Secondary Analysis of the Women's Health Initiative Randomized Clinical Trials.
    Neuhouser ML; Aragaki AK; Prentice RL; Manson JE; Chlebowski R; Carty CL; Ochs-Balcom HM; Thomson CA; Caan BJ; Tinker LF; Urrutia RP; Knudtson J; Anderson GL
    JAMA Oncol; 2015 Aug; 1(5):611-21. PubMed ID: 26182172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.